LOC728323 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.733200E-01
Normal-vs-Stage2
7.939800E-01
Normal-vs-Stage3
2.172200E-01
Normal-vs-Stage4
7.496800E-01
Stage1-vs-Stage2
3.324400E-01
Stage1-vs-Stage3
1.118190E-01
Stage1-vs-Stage4
8.939600E-01
Stage2-vs-Stage3
7.637100E-04
Stage2-vs-Stage4
5.360000E-01
Stage3-vs-Stage4
8.895900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.201600E-01
Normal-vs-AfricanAmerican
7.598200E-01
Normal-vs-Asian
5.168400E-01
Caucasian-vs-AfricanAmerican
3.853400E-01
Caucasian-vs-Asian
4.124600E-01
AfricanAmerican-vs-Asian
2.339800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.522600E-01
Normal-vs-Female
8.786400E-01
Male-vs-Female
5.378800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.801200E-01
Normal-vs-Age(41-60Yrs)
9.568000E-01
Normal-vs-Age(61-80Yrs)
7.540000E-01
Normal-vs-Age(81-100Yrs)
6.205200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.190400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.927400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.353200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.930000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.617600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.877200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.128000E-01
Normal-vs-Daily Drinker
1.645570E-01
Normal-vs-Weekly Drinker
7.098200E-01
Normal-vs-Occasional Drinker
9.179200E-01
Normal-vs-Social Drinker
8.195200E-01
Non Drinker-vs-Daily Drinker
1.536590E-01
Non Drinker-vs-Weekly Drinker
9.001600E-01
Non Drinker-vs-Occasional Drinker
3.552400E-01
Non Drinker-vs-Social Drinker
2.594200E-01
Daily Drinker-vs-Weekly Drinker
1.217800E-01
Daily Drinker-vs-Occasional Drinker
4.175900E-02
Daily Drinker-vs-Social Drinker
2.892100E-02
Weekly Drinker-vs-Occasional Drinker
4.694800E-01
Weekly Drinker-vs-Social Drinker
3.408000E-01
Occasional Drinker-vs-Social Drinker
8.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.559000E-03
Normal-vs-Grade 2
2.083600E-01
Normal-vs-Grade 3
1.544410E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.576600E-01
Grade 1-vs-Grade 3
5.665200E-01
Grade 1-vs-Grade 4
1.559000E-03
Grade 2-vs-Grade 3
5.149600E-01
Grade 2-vs-Grade 4
2.083600E-01
Grade 3-vs-Grade 4
1.544410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.026800E-01
Normal-vs-NonDiabetic
7.124400E-01
Diabetic-vs-NonDiabetic
5.954600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.015800E-01
Normal-vs-NoPancreatitis
8.017600E-01
Pancreatitis-vs-NoPancreatitis
3.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.638400E-01
Normal-vs-N1
8.001200E-01
N0-vs-N1
8.377200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.333600E-01
Normal-vs-TP53-NonMutant
9.121400E-01
TP53-Mutant-vs-TP53-NonMutant
1.014250E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
